Checkpoint Therapeutics (NASDAQ:CKPT – Get Rating) had its target price reduced by LADENBURG THALM/SH SH from $96.00 to $69.00 in a research note released on Monday morning, The Fly reports. They currently have a buy rating on the stock. A number of other research analysts also recently issued reports on CKPT. Lake Street Capital reduced […]